ArticleProtein and peptide letters2025

Mevalonate Metabolic Reprogramming Drives Cisplatin Resistance in Bladder Cancer: Mechanisms and Therapeutic Targeting.

Qixiang Fang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.